Login / Signup

Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma.

Cheng ZhouZhang-Fu YangBao-Ye SunYong YiZheng WangJian ZhouJia FanWei GanNing RenShuang-Jian Qiu
Published in: Journal of hepatocellular carcinoma (2023)
. Antibodies against PD-1/PD-L1 can enhance the efficacy of lenvatinib in the management of hepatocellular carcinoma.
Keyphrases
  • toll like receptor
  • cell death
  • nuclear factor
  • inflammatory response
  • immune response
  • cell cycle arrest
  • signaling pathway